Save information for later
Sign Up

Learn About Fanconi Bickel Syndrome

What is the definition of Fanconi Bickel Syndrome?
Fanconi Bickel syndrome (FBS) is a rare condition characterized by the accumulation of a substance called glycogen in different parts of the body. Glycogen is created when the body needs to store glucose (sugar). When the body needs sugar again, glycogen is transformed back into glucose for use. People with Fanconi Bickel syndrome do not store the appropriate amount of glycogen. Therefore, Fanconi Bickel syndrome is known as a glycogen storage disease. Specifically, glycogen accumulates in the liver and kidneys. Signs and symptoms begin in the first few months of life and include growing slower than expected (failure to thrive), excessive urination (polyuria), and weakened bones (rickets). Later in life, children may have short stature and a swollen liver and spleen (hepatosplenomegaly). Fanconi Bickel syndrome is caused by genetic changes to the SLC2A2 gene and is inherited in an autosomal recessive manner. Diagnosis of FBS is based on a clinical examination that shows signs of FBS. The condition can be confirmed by genetic testing.
What are the alternative names for Fanconi Bickel Syndrome?
  • Fanconi Bickel syndrome
  • Fanconi syndrome with intestinal malabsorption and galactose intolerance
  • GLUT2 deficiency
  • Glycogen storage disease XI
  • Glycogen storage disease due to GLUT2 deficiency
  • Glycogenosis Fanconi type
  • Hepatic glycogenosis with amino aciduria and glucosuria
  • Hepatorenal glycogenosis with renal Fanconi syndrome
  • Pseudo-Phlorizin diabetes
Who are the top Fanconi Bickel Syndrome Local Doctors?
Christophe Sirac
Elite in Fanconi Bickel Syndrome
Elite in Fanconi Bickel Syndrome
Limoges, FR 

Christophe Sirac practices in Limoges, France. Mr. Sirac and is rated as an Elite expert by MediFind in the treatment of Fanconi Bickel Syndrome. His top areas of expertise are Fanconi Syndrome, Fanconi Bickel Syndrome, Aminoaciduria, Light Chain Deposition Disease (LCDD), and Kidney Transplant.

Elite in Fanconi Bickel Syndrome
Elite in Fanconi Bickel Syndrome
Leuven, VLG, BE 

Elena Levtchenko practices in Leuven, Belgium. Ms. Levtchenko and is rated as an Elite expert by MediFind in the treatment of Fanconi Bickel Syndrome. Her top areas of expertise are Cystinosis, Fanconi Bickel Syndrome, Fanconi Syndrome, Lowe Syndrome, and Kidney Transplant.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Fanconi Bickel Syndrome
Elite in Fanconi Bickel Syndrome

Great Ormond Street Hospital For Children NHS Foundation Trust

London, ENG, GB 

Detlef Bockenhauer practices in London, United Kingdom. Bockenhauer and is rated as an Elite expert by MediFind in the treatment of Fanconi Bickel Syndrome. Their top areas of expertise are Nephrocalcinosis, Bartter Syndrome, Aminoaciduria, Osteotomy, and Lithotripsy.

What are the latest Fanconi Bickel Syndrome Clinical Trials?
Etiologic Investigation of Cancer Susceptibility in Inherited Bone Marrow Failure Syndromes: A Natural History Study

Background: A prospective cohort of Inherited Bone Marrow Failure Syndrome (IBMFS) will provide new information regarding cancer rates and types in these disorders. Pathogenic variant(s) in IBMFS genes are relevant to carcinogenesis in sporadic cancers. Patients with IBMFS who develop cancer differ in their genetic and/or environmental features from patients with IBMFS who do not develop cancer. These cancer-...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Coordination of Rare Diseases at Sanford

Summary: CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, in...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center